Background: In developing countries, postpartum hemorrhage is responsible for 30% of
maternal deaths. Although the World Health Organization recommends the use of oxytocin …

Background There is some evidence that suggests misoprostol may supplement the action
of oxytocin in preventing post-partum haemorrhage (PPH). The primary objective of this …

Objective: This randomised comparative clinical trial aimed to assess the effectiveness and
tolerability of combining oxytocin and misoprostol for preventing immediate postpartum …

Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide.
Studies suggest that the use of misoprostol may be beneficial in clinical settings where …

Background: In low-resource regions of world, misoprostol, with or without oxytocin, has
recently emerged as an effective substitute for oxytocin for preventing postpartum …

Objective: To compare low dose sublingual misoprostol with the standard 10 IU of
intramuscular oxytocin in active management of third stage of labor. Materials and Methods …

Objective The study aimed to compare the effectiveness and side effects of 600 μg of oral
Misoprostol with 10 international units (IU) intramuscular oxytocin in managing the third …

Post-partum hemorrhage (PPH) is a common cause of maternal mortality in developing
countries. Active management of postpartum hemorrhage by an uterotonic drug decreases …

Background: Post-partum hemorrhage (PPH) is a leading cause of maternal mortality. Its first-
line of prevention often entails uterotonic drugs like oxytocin and misoprostol which …

Background Postpartum hemorrhage (PPH) is a leading cause of maternal death in sub-
Saharan Africa. Although the World Health Organization recommends use of oxytocin for …